Li Ning Li
Director/Board Member at HaploX Investment Holding Ltd.
Li Ning Li active positions
| Companies | Position | Start | End |
|---|---|---|---|
HaploX Investment Holding Ltd.
 HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Director/Board Member | 29/01/2023 | - |
Career history of Li Ning Li
Former positions of Li Ning Li
| Companies | Position | Start | End |
|---|---|---|---|
| Grains Valley Venture Capital | Chief Operating Officer | 01/01/2009 | 02/01/2009 |
Training of Li Ning Li
| University of Cardiff | Graduate Degree |
| China Pharmaceutical University | Undergraduate Degree |
Statistics
International
| China | 3 |
| United Kingdom | 2 |
| Cayman Islands | 2 |
Operational
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
| Grains Valley Venture Capital | |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |
- Stock Market
- Insiders
- Li Ning Li
- Experience
